Avidicure: Funding, Investors & Team (Sep 2026)
Avidicure is leading the way in developing a new type of antibody treatment called "AVC-Boosters", which have dual agonistic capabilities and are engineered for increased avidity. These antibodies are designed to effectively and safely deliver potent monotherapy for cancer treatment, with a wide range of potential uses in the field of oncology.
Avidicure has raised $50.0M across 1 funding round on record, the most recent a Seed of $50.0M announced in Apr 2025.
That round is above the $3.0M median round size for Biotechnology Research companies tracked on FundedIQ over the last two years.
Avidicure Company Profile and Key Stats
Latest funding round on record: Apr 2025.
Avidicure Funding Rounds
Avidicure Founders and Leadership Team
Contact details for the Avidicure team: 1 of 1 has an email address on file.
Start 14-day free trial →Avidicure Funding Compared to Other Biotechnology Research Startups
Avidicure's latest round of $50.0M is above the median round in Biotechnology Research. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Avidicure in Biotechnology Research and South Holland
Companies Similar to Avidicure
FibroBiologics is a regenerative medicine firm situated in Houston, Texas that is working on an inventive…
FoamLab specializes in high-performance, bio-based foams made from bacterial nanocellulose and develops a new…
Intrinsic Foundries is pioneering carbon capture and utilization technology that converts industrial waste…
Auxilium Biotechnologies specializes in developing technology for repairing peripheral nerves.
Expedition Medicine's industry-leading chemoproteomics data generating engine learns the rules of molecular…
Orange Grove Bio (OGB) is a platform that specializes in investing and developing preclinical drugs, with the…
The Verschuren Centre assists in the advancement of sustainable technologies for cleantech companies and…
A new class of programmable polymer nanoparticles is being developed by Nanite, a next-generation non-viral…
a nonprofit organisation dedicated to reducing greenhouse gas emissions by genetically increasing CO2…
Love Lifesciences is creating a line of injection safety tools that will enhance patient comfort when…
Empatica is a startup that specializes in emotional computing and human data analytics. We create…
Cybele utilizes unique technology to deliver high-effective solutions for human health.
Avidicure Funding FAQs
What does Avidicure do?
Avidicure is leading the way in developing a new type of antibody treatment called "AVC-Boosters", which have dual agonistic capabilities and are engineered for increased avidity. These antibodies are designed to effectively and safely deliver potent monotherapy for cancer treatment, with a wide range of potential uses in the field of oncology.
How much funding has Avidicure raised?
Avidicure has raised $50.0M across 1 round on record. The most recent is a Seed of $50.0M announced in Apr 2025.
When did Avidicure last raise funding?
Avidicure's most recent funding round on record is a Seed of $50.0M, announced in Apr 2025.
Who founded Avidicure?
FundedIQ lists Robert Friesen (Founder) at Avidicure.
Where is Avidicure headquartered?
Avidicure is based in South Holland, Illinois, United States.
How many employees does Avidicure have?
Avidicure is in the 11-50 employee band.
How does Avidicure's funding compare to other Biotechnology Research startups?
Avidicure's latest round of $50.0M is above the $3.0M median round size for Biotechnology Research companies on FundedIQ across 24 tracked companies over the last two years.
About FundedIQ's Avidicure Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Avidicure is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.